Clinical Trials

Showing trials with last updates posted in 2015.

NCT01306617 | COMPLETED | PHASE2
50 participants

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Study Type:
INTERVENTIONAL
Last Updated:
2015-01-08
Start Date:
2011-02-28
Completion:
2011-11-30
Conditions
  • Chronic Hepatitis C Infection
  • Hepatitis C
  • Hepatitis C Virus
Interventions
  • DRUG
NCT00509249 | TERMINATED | PHASE2
18 participants

Aflibercept in Treating Patients With Myelodysplastic Syndromes

Study Type:
INTERVENTIONAL
Last Updated:
2015-01-08
Start Date:
2007-09-30
Completion:
2010-12-31
Conditions
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • Chronic Myelomonocytic Leukemia
  • de Novo Myelodysplastic Syndromes
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Previously Treated Myelodysplastic Syndromes
  • Secondary Myelodysplastic Syndromes
Interventions
  • BIOLOGICAL
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page